Details for New Drug Application (NDA): 205683
✉ Email this page to a colleague
The generic ingredient in MONTELUKAST SODIUM is montelukast sodium. There are thirty-five drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.
Summary for 205683
Tradename: | MONTELUKAST SODIUM |
Applicant: | Anbison Lab |
Ingredient: | montelukast sodium |
Patents: | 0 |
Pharmacology for NDA: 205683
Mechanism of Action | Leukotriene Receptor Antagonists |
Suppliers and Packaging for NDA: 205683
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 205683 | ANDA | Westminster Pharmaceuticals, LLC | 69367-287 | 69367-287-05 | 500 TABLET in 1 BOTTLE (69367-287-05) |
MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 205683 | ANDA | Westminster Pharmaceuticals, LLC | 69367-287 | 69367-287-09 | 90 TABLET in 1 BOTTLE (69367-287-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jan 12, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription